Skip to content

How bleeding complications and costs can be reduced?

INTERNATIONAL EXPERTS MEETING
Optimizing patient management with CytoSorb Hemoperfusion Therapy in Cardiac Surgery – Scientific evidence and clinical practice

Reduce bleeding complications in Ticagrelor and Rivaroxaban treated patients undergoing emergency Cardiac Surgery
Chair: Prof. Michael Schmoeckel, Hamburg/Germany

How bleeding complications and costs can be reduced?
Dr. Stephan Geidel, Hamburg/Germany

Play Video

Share

|

How bleeding complications and costs can be reduced?

Play Video

Share

|

INTERNATIONAL EXPERTS MEETING
Optimizing patient management with CytoSorb Hemoperfusion Therapy in Cardiac Surgery – Scientific evidence and clinical practice

Reduce bleeding complications in Ticagrelor and Rivaroxaban treated patients undergoing emergency Cardiac Surgery
Chair: Prof. Michael Schmoeckel, Hamburg/Germany

How bleeding complications and costs can be reduced?
Dr. Stephan Geidel, Hamburg/Germany

More Videos

Welcome & Introduction | Stefan Baudis | Webinar 1 | 2021
Welcome & Introduction | Stefan Baudis | Webinar 1 | 2021
How bleeding complications and costs can be reduced? | Stephan Geidel | Webinar 1 | 2021
How bleeding complications and costs can be reduced? | Stephan Geidel | Webinar 1 | 2021
Jak można ograniczyć powikłania krwotoczne i koszty? | Stephan Geidel | With Polish Voice Over
Jak można ograniczyć powikłania krwotoczne i koszty? | Stephan Geidel | With Polish Voice Over
Do we have a novel treatment approach to avoid re-thoracotomies? | Nikola Bradic | Webinar 1 | 2021
Do we have a novel treatment approach to avoid re-thoracotomies? | Nikola Bradic | Webinar 1 | 2021
Why is it relevant? | Robert F Storey | Webinar 1 | 2021
Why is it relevant? | Robert F Storey | Webinar 1 | 2021